While we have been talking about using brexanolone, marketed by Sage Therapeutics as Zulresso, for the treatment of postpartum depression, an oral version of this novel antidepressant - SAGE 217 or zuranolone - has [...]
When providing information to patients regarding the use of medications during pregnancy, one key element of the decision-making process is an appraisal of the risks associated with untreated psychiatric illness in the mother. While there [...]
While the use of lithium has been in decline over the last 20 years, lithium continues to be a useful and highly effective mood stabilizer for women with bipolar disorder. We have long been aware [...]
Women who have a shorter interpregnancy interval, typically defined as less 12 months, experience higher rates of pregnancy complications. In addition there is accumulating dated to suggest that there are higher risks of neurodevelopmental problems, [...]
Anxiety disorders affect nearly 1 in 5 adults in the United States, and women are about twice as likely as men to suffer from an anxiety disorder at some point in their lifetime. According to [...]
For women with bipolar disorder, choosing whether to maintain or discontinue treatment with a mood stabilizer during pregnancy is challenging. This is a process which requires careful and thoughtful consideration, weighing the risk of adverse [...]
According to a recent meta-analysis published in the Journal of Clinical Psychiatry, one in five pregnant women experience at least one type of anxiety disorder. While this may be surprising to some, anybody who works [...]
While we have considerable information regarding the teratogenic risk associated with prenatal exposure to various antiepileptic (AED) drugs, we have less impact on exposure to AEDs on behavior outcomes in children. Several studies have shown [...]
Clinically we see that many women with major depressive disorder and bipolar disorder experience worsening of their symptoms prior to the onset of menses. We have less data on the impact of menstrual cycle on [...]
There is a growing body of literature which indicates that anxiety symptoms are common during pregnancy and the postpartum period. Â Anxiety during pregnancy places the woman at greater risk for postpartum depression and may also [...]
